6-phosphogluconate dehydrogenase
AssigneeSmithKline Beecham Corporation
InventorRichard Lloyd Warren
Life of this patent
Estimating the term…
Abstract
The invention provides 6-phosphogluconate dehydrogenase polypeptides and polynucleotides encoding 6-phosphogluconate dehydrogenase polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing 6-phosphogluconate dehydrogenase polypeptides to screen for antibacterial compounds.
Claims14
An isolated polypeptide comprising SEQ ID NO:2.
An isolated polypeptide comprising a fragment of SEQ ID NO:2 comprising at least 50 consecutive amino acids of SEQ ID NO:2;
- wherein the fragment exhibits 6-phosphogluconate dehydrogenase activity.
An isolated polypeptide comprising a fragment of SEQ ID NO:2 comprising at least 30 consecutive amino acids of SEQ ID NO:2;
- wherein the fragment exhibits 6-phosphogluconate dehydrogenase activity.
An isolated polypeptide comprising a fragment of SEQ ID NO:2, wherein the fragment comprises at least 50 consecutive amino acids of SEQ ID NO:2 and wherein the polypeptide can generate antibodies specific to SEQ ID NO:2.
An isolated polypeptide comprising a fragment of SEQ ID NO:2, wherein the fragment comprises at least 30 consecutive amino acids of SEQ ID NO:2 and wherein the polypeptide can generate antibodies specific to SEQ ID NO:2.
Dependencies are inferred from the claim text.